Drug Trial Radar · NCT06162611
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
790
Planned (sponsor's estimate)
Start
Nov 6, 2023
Primary completion
Apr 30, 2028
Study completion May 31, 2028
Sponsor
- Lead sponsor
- Lori GawronAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Planned Parenthood Association of Utah
- First posted
- Dec 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Intrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This proposal will identify the most effective way to start an implant for emergency contraception using a randomized controlled trial comparing pregnancy risk between those receiving the implant vs. the implant plus oral emergency contraception (EC). Data from this project will inform clinical practice and add another option, the implant, for those desiring a long acting, highly effective contraceptive method when they present for emergency contraception.
Conditions
- Emergency Contraception
Interventions
Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mgDrug
Single pill of oral levonorgestrel 1.5mg X 1 dose (e.g. Plan B) same day as contraceptive implant insertion
Etonogestrel implant with oral placeboDevice
Single pill of placebo same day as contraceptive implant insertion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraceptionTime frame: 1 month after enrollment
- Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraception by BMI categoryTime frame: 1 month after enrollment
- Efficacy of the etonogestrel contraceptive implant with oral levonorgestrel for emergency contraceptionTime frame: 1 month after enrollment
- Efficacy of the etonogestrel contraceptive implant with oral levonorgestrel for emergency contraception by BMI categoryTime frame: 1 month after enrollment
- Ovulation frequency within 5 days of implant insertion in the oral levonorgestrel armTime frame: 5 days after implant insertion
- Ovulation frequency within 5 days of implant insertion in the placebo armTime frame: 5 days after implant insertion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Planned Parenthood Association of Utah
Salt Lake City, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.